Nurix Therapeutics (NRIX) Cash from Operations Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nurix Therapeutics |
1.93 Bn |
1.39 Bn |
- |
-17.72% |
| Date | Value |
|---|
| Feb 28, 2026 |
-17.72% |
| Nov 30, 2025 |
-39.14% |
| Aug 31, 2025 |
-36.06% |
| May 31, 2025 |
-59.08% |
| Feb 28, 2025 |
-45.62% |
| Nov 30, 2024 |
-282.66% |
| Aug 31, 2024 |
-2.54% |
| May 31, 2024 |
-114.98% |
| Feb 29, 2024 |
13.42% |
| Nov 30, 2023 |
170.32% |
| Aug 31, 2023 |
11.18% |
| May 31, 2023 |
43.89% |
| Feb 28, 2023 |
-13.66% |
| Nov 30, 2022 |
-22.79% |
| Aug 31, 2022 |
-54.50% |
| May 31, 2022 |
-4.37% |
| Feb 28, 2022 |
-629.37% |
| Nov 30, 2021 |
-50.92% |
| Aug 31, 2021 |
-388.06% |
| May 31, 2021 |
-118.55% |
